• Molecular NameTamibarotene
  • SynonymAm 80; retinobenzoic acid; Tamibarotene
  • Weight351.446
  • Drugbank_IDDB04942
  • ACS_NO94497-51-5
  • Show 3D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)5.36
  • pkaN/A
  • LogD (pH=7, predicted)2.21
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-3.14
  • LogSw (predicted, AB/LogsW2.0)0.0
  • Sw (mg/ml) (predicted, ACD/Labs)0.0
  • No.of HBond Donors2
  • No.of HBond Acceptors4
  • No.of Rotatable Bonds3
  • TPSA66.4
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyOrally active, synthetic retinoid, developed to overcome all-trans retinoic acid (ATRA) resistance, with potential antineoplastic activity.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein binding99.0
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A